Cite

    Ward, M., Flemming, N., Gallo, L., Fotheringham, A., McCarthy, D., Zhuang, A., Tang, P., Borg, D., Shaw, H., Harvie, B., Briskey, D., Roberts, L., Plan, M., Murphy, M., Hodson, M., & Forbes, J. (2017). targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes. Scientific reports, 7(1), 1–14. http://access.bl.uk/ark:/81055/vdc_100086838040.0x00002a